Cargando…
P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Autores principales: | Broijl, A., van de Donk, N., Bosch, F., Mateos, M. V., Rodriguez-Otero, P., Tucci, A., Ghia, P., Adang, A., Parren, P., Tuinhof, I., Umarale, S., Winograd, B., van der Vliet, H., Kater, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430685/ http://dx.doi.org/10.1097/01.HS9.0000848708.67906.8b |
Ejemplares similares
-
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
por: Lameris, Roeland, et al.
Publicado: (2023) -
The Medicines of Katherine, Duchess of Norfolk, 1463–71
por: Kleineke, Hannes
Publicado: (2015) -
Public life in Toulouse, 1463-1789 : from municipal republic to cosmopolitan city /
por: Schneider, Robert Alan
Publicado: (1989) -
Dielectric permittivity of lava-like fuel containing materials
por: Moina, A P
Publicado: (2001) -
(PO-051) Catatonic with COVID-19
por: Patel, Prit, et al.
Publicado: (2022)